Sorrento Therapeutics, Inc. (SRNE)
OTCMKTS · Delayed Price · Currency is USD
0.0021
-0.0043 (-67.19%)
Aug 15, 2025, 3:50 PM EDT
Sorrento Therapeutics Market Cap
Sorrento Therapeutics has a market cap or net worth of $1.14 million as of August 15, 2025. Its market cap has decreased by -72.00% in one year.
Market Cap
1.14M
Enterprise Value
n/a
Revenue
64.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 24, 2009, Sorrento Therapeutics's market cap has decreased from 112.54M to 1.14M, a decrease of -98.99%. That is a compound annual growth rate of -25.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 1.14M | 320.00% |
| Dec 31, 2024 | 271.86K | -99.60% |
| Dec 29, 2023 | 67.15M | -83.68% |
| Dec 30, 2022 | 411.38M | -71.18% |
| Dec 31, 2021 | 1.43B | -18.09% |
| Dec 31, 2020 | 1.74B | 240.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 567.91M |
| Elite Pharmaceuticals | 567.29M |
| American Oncology Network | 389.51M |
| Northwest Biotherapeutics | 362.70M |
| CytoDyn | 336.73M |